- An experimental drug to treat Alzheimer's disease just failed a late-stage trial.
- "
ADVERTISEMENT
The search for a new Alzheimer's treatment just hit another setback (VTVT)
The treatment, when compared to placebo, "did not improve in cognitive or functional outcomes." VTV Therapeutics is discontinuing its clinical trials.
ADVERTISEMENT
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
10 African countries with the lowest inflation rates in 2024
Davido launches his label Nine+ in partnership with UnitedMasters
Nigeria's economic ranking drops to fourth in Africa
Moscow inaugurates its House of Africa
The CBN justifies $2b billion loss in forex, dispelling Naira defense claims
10 best airports in Africa in 2024
10 most expensive cities in Africa in 2024
Illegal money changers adapt to Zimbabwe's ZiG currency rollout